178 related articles for article (PubMed ID: 9257944)
21. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
22. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
Audinot V; Newman-Tancredi A; Gobert A; Rivet JM; Brocco M; Lejeune F; Gluck L; Desposte I; Bervoets K; Dekeyne A; Millan MJ
J Pharmacol Exp Ther; 1998 Oct; 287(1):187-97. PubMed ID: 9765337
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the functional potencies of ropinirole and other dopamine receptor agonists at human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells.
Coldwell MC; Boyfield I; Brown T; Hagan JJ; Middlemiss DN
Br J Pharmacol; 1999 Aug; 127(7):1696-702. PubMed ID: 10455328
[TBL] [Abstract][Full Text] [Related]
24. D2 dopamine receptors and modulation of spontaneous acetylcholine (ACh) release from rat striatal synaptosomes.
Clos MV; García-Sanz A; Vivas NM; Badia A
Br J Pharmacol; 1997 Sep; 122(2):286-90. PubMed ID: 9313937
[TBL] [Abstract][Full Text] [Related]
25. Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297.
Rivet JM; Audinot V; Gobert A; Peglion JL; Millan MJ
Eur J Pharmacol; 1994 Nov; 265(3):175-7. PubMed ID: 7875234
[TBL] [Abstract][Full Text] [Related]
26. Biphasic inhibition of stimulated endogenous dopamine release by 7-OH-DPAT in slices of rat nucleus accumbens.
Patel J; Trout SJ; Palij P; Whelpton R; Kruk ZL
Br J Pharmacol; 1995 Jun; 115(3):421-6. PubMed ID: 7582452
[TBL] [Abstract][Full Text] [Related]
27. Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat.
Caine SB; Geyer MA; Swerdlow NR
Neuropsychopharmacology; 1995 Apr; 12(2):139-45. PubMed ID: 7779242
[TBL] [Abstract][Full Text] [Related]
28. 4-(2'-Methoxy-phenyl)-1-[2'-(n-2"-pyridinyl)-p-iodobenzamido]-ethyl- piperazine ([125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies.
Kung MP; Frederick D; Mu M; Zhuang ZP; Kung HF
J Pharmacol Exp Ther; 1995 Jan; 272(1):429-37. PubMed ID: 7815360
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and optical resolution of (R)- and (S)-trans-7-Hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino]tetralin: a new D3 dopamine receptor ligand.
Chumpradit S; Kung MP; Kung HF
J Med Chem; 1993 Dec; 36(26):4308-12. PubMed ID: 8277513
[TBL] [Abstract][Full Text] [Related]
30. Ontogeny of dopamine D3 receptors in the nucleus accumbens of the rat.
Stanwood GD; McElligot S; Lu L; McGonigle P
Neurosci Lett; 1997 Feb; 223(1):13-6. PubMed ID: 9058411
[TBL] [Abstract][Full Text] [Related]
31. Evidence that dopamine D3 receptors participate in clozapine-induced hypothermia.
Millan MJ; Audinot V; Melon C; Newman-Tancredi A
Eur J Pharmacol; 1995 Jul; 280(2):225-9. PubMed ID: 7589191
[TBL] [Abstract][Full Text] [Related]
32. Identification and localization of dopamine receptor subtypes in rat olfactory mucosa and bulb: a combined in situ hybridization and ligand binding radioautographic approach.
Coronas V; Srivastava LK; Liang JJ; Jourdan F; Moyse E
J Chem Neuroanat; 1997 May; 12(4):243-57. PubMed ID: 9243344
[TBL] [Abstract][Full Text] [Related]
33. Functional and autoradiographic characterization of dopamine D2-like receptors in the guinea pig heart.
Gómez Mde J; Rousseau G; Nadeau R; Berra R; Flores G; Suárez J
Can J Physiol Pharmacol; 2002 Jun; 80(6):578-87. PubMed ID: 12117307
[TBL] [Abstract][Full Text] [Related]
34. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
Pugsley TA; Davis MD; Akunne HC; MacKenzie RG; Shih YH; Damsma G; Wikstrom H; Whetzel SZ; Georgic LM; Cooke LW
J Pharmacol Exp Ther; 1995 Dec; 275(3):1355-66. PubMed ID: 8531103
[TBL] [Abstract][Full Text] [Related]
35. Characterization of binding of [3H]PD 128907, a selective dopamine D3 receptor agonist ligand, to CHO-K1 cells.
Akunne HC; Towers P; Ellis GJ; Dijkstra D; Wikström H; Heffner TG; Wise LD; Pugsley TA
Life Sci; 1995; 57(15):1401-10. PubMed ID: 7674830
[TBL] [Abstract][Full Text] [Related]
36. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
[TBL] [Abstract][Full Text] [Related]
37. Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys.
Spealman RD
J Pharmacol Exp Ther; 1996 Sep; 278(3):1128-37. PubMed ID: 8819495
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the human dopamine D3 receptor expressed in transfected cell lines.
MacKenzie RG; VanLeeuwen D; Pugsley TA; Shih YH; Demattos S; Tang L; Todd RD; O'Malley KL
Eur J Pharmacol; 1994 Jan; 266(1):79-85. PubMed ID: 7907989
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo characterization of R(+)-FIDA2: a dopamine D2-like imaging agent.
Vessotskie JM; Kung MP; Chumpradit S; Romaniello G; McElgin W; Frederick D; Malison RT; Kung HF
J Nucl Med; 1995 Jul; 36(7):1282-8. PubMed ID: 7790957
[TBL] [Abstract][Full Text] [Related]
40. Identification of D3 and sigma receptors in the rat striatum and nucleus accumbens using (+/-)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin and carbetapentane.
Wallace DR; Booze RM
J Neurochem; 1995 Feb; 64(2):700-10. PubMed ID: 7830063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
